Care at a specialty center is tied to a lower risk of hospitalization for people with heart failure with preserved ejection fraction…
Articles by Marisa Wexler, MS
Children with pulmonary arterial hypertension (PAH) report poorer health-related quality of life (HRQoL) than their peers, a study shows.
Aerovate Therapeutics is starting a Phase 2b/3 clinical trial that will test AV-101, the company’s experimental inhaled formulation of imatinib,…
Beyond Air has announced that it is not expecting the U.S. Food and Drug Administration (FDA) to approve its …
Treatment with the experimental medication KER-012 helped to prevent heart damage in a mouse model of pulmonary hypertension,…
By analyzing how medications affect the genetic activity of cells, researchers developed a computational pipeline that may be useful in…
Due to problems at a third-party facility, the U.S. Food and Drug Administration (FDA) has decided to not approve Tyvaso…
People with pulmonary hypertension (PH) who start treatment with opioids to manage pain after undergoing surgery are at high…
The U.S. Food and Drug Administration (FDA) has cleared Tenax Therapeutics to begin clinical testing of its new oral…
Targeting a protein called p110a, a part of the PI3K family of enzymes, may be useful for preventing or even…
A lab version of an investigational treatment for bone disorders and pulmonary arterial hypertension (PAH), KER-012Â prevented bone loss…
Blocking the activity of a small RNA molecule called microRNA-30a eased alterations in heart structure and blood vessel architecture in…